EZCORP Acquires Controlling Interest in Founders One, LLC, Expanding Its Footprint by 105 Pawn Stores Across 12 Countries

(NASDAQ:EZPW), AUSTIN, Texas, Jan. 05, 2026 (GLOBE NEWSWIRE) — EZCORP, Inc. (NASDAQ:EZPW) (“EZCORP” or the “Company”), a leading provider of pawn loans in the United States and Latin America, announced today the acquisition of a controlling interest in Founders One, LLC (“Founders”). Founders, through its subsidiary, Simple Management Group, Inc. (“SMG”), led by CEO John […]

OraSure Submits CT/NG Molecular Self-Test and Colli-Pee(TM) Urine Collection Device for FDA Review

(NASDAQ:OSUR), BETHLEHEM, Pa., Jan. 05, 2026 (GLOBE NEWSWIRE) — OraSure Technologies, Inc. (NASDAQ: OSUR) (“OraSure” and “OTI”), a leader in point-of-need and home diagnostic tests and sample management solutions, today announced that it submitted two separate applications at the end of 2025 to the U.S. Food and Drug Administration (FDA) for clearance of its rapid

Geely Auto Selects Cerence xUI to Power its Next-Gen, LLM-Powered In-Car AI Experience

(NASDAQ:CRNC), LAS VEGAS and BURLINGTON, Mass., Jan. 05, 2026 (GLOBE NEWSWIRE) — CES 2026 — Cerence Inc. (NASDAQ: CRNC) (“Cerence AI”), a global technology leader in conversational AI-powered user experiences, today announced that Geely Auto will deploy Cerence xUI(TM), the company's hybrid, agentic AI platform, to comprehensively upgrade the automaker's overseas in-vehicle voice interaction experience.

Rogers Launches The Great Canadian Jersey

(TSX:RCI-A),(TSX:RCI-B),(NYSE:RCI), – Donate your old hockey jerseys to be a part of hockey history – – Connor McDavid and Marie-Philip Poulin kick-off donations today – TORONTO, Jan. 05, 2026 (GLOBE NEWSWIRE) — Rogers launched today The Great Canadian Jersey, the latest installment of Rogers This Is Our Game campaign. The Great Canadian Jersey invites Canadians

SpotOn GPS Fence launches the Nova Edition: A GPS fence offering 100% reliability

Manchester, New Hampshire, Jan. 05, 2026 (GLOBE NEWSWIRE) — For dog owners, reliable containment solutions have often come with difficult tradeoffs between costly fence installation or the lack of flexibility in alternative fence solutions. SpotOn GPS Fence, the original GPS Fence solution for dogs, has changed that for nearly a decade, giving dogs true freedom

AmpliTech Group Reports Unaudited Record FY2025 Revenue And Reaffirms $50M + FY2026 Revenue Outlook

(NASDAQ:AMPG),(NASDAQ:AMPGW), HAUPPAUGE, N.Y., Jan. 05, 2026 (GLOBE NEWSWIRE) — AmpliTech Group, Inc. (NASDAQ: AMPG) (“AmpliTech” or the “Company”) today announced unaudited record full-year revenue of approximately $25 million for fiscal year 2025, up 163% YoY, exceeding analyst's expectations given at the beginning of the year and meeting the Company's publicly issued revenue guidance. Building on

Greif, Inc. Announces 2026 First Quarter Earnings Release and Conference Call Dates

(NYSE:GEF),(NYSE:GEF.B),(NYSE:GEF-B), DELAWARE, Ohio, Jan. 05, 2026 (GLOBE NEWSWIRE) — Greif, Inc. (NYSE: GEF, GEF.B), a global leader in industrial packaging products and services, announced today it will report the company's 2026 first quarter financial results after the market closes on Tuesday, January 28, 2026. A conference call will be held on Wednesday, January 29, 2026,

Ceribell Receives FDA Breakthrough Device Designation for LVO Stroke Detection and Monitoring Solution

(NASDAQ:CBLL), SUNNYVALE, Calif., Jan. 05, 2026 (GLOBE NEWSWIRE) — CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation for its Large Vessel Occlusion (LVO) stroke detection monitor

BlossomHill Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12

SAN DIEGO, Jan. 05, 2026 (GLOBE NEWSWIRE) — BlossomHill Therapeutics, Inc., a privately-held, clinical-stage biopharmaceutical company focused on the design and development of next-generation medicines for cancer, today announced the company will present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026 at 2:00 p.m. PT. J. Jean Cui, Ph.D., President

Humacyte Announces Planned Marketing Authorization Application for Symvess(R) in Israel

(NASDAQ:HUMA), – Expansion plans are based on requests for product access received from surgeons and hospitals in Israel – – Expansion of Symvess into other territories, including those in Europe and the Middle East, is also planned – DURHAM, N.C., Jan. 05, 2026 (GLOBE NEWSWIRE) — Humacyte, Inc. (Nasdaq: HUMA), a commercial-stage biotechnology platform company

Scroll to Top